Modi Biotech Profile
Key Indicators
- Authorised Capital ₹ 17.50 Cr
as on 04-11-2024
- Paid Up Capital ₹ 17.50 Cr
as on 04-11-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 137.82 Cr
as on 04-11-2024
- Revenue %
(FY 2023)
- Profit -179.18%
(FY 2023)
- Ebitda -112.84%
(FY 2023)
- Net Worth 106.28%
(FY 2023)
- Total Assets 722.31%
(FY 2023)
About Modi Biotech
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 17.50 Cr and a paid-up capital of Rs 17.50 Cr.
The company currently has active open charges totaling ₹137.82 Cr.
The Key Managerial Personnel (KMP) at Modi Biotech Private Limited India is Ankit Agarwal as COMPANY SECRETARY. Anil Modi and Akshay Modi serve as directors at the Company.
- CIN/LLPIN
U24299DL2021PTC380622
- Company No.
380622
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Apr 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Modi Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ankit Agarwal | Company Secretary | 18-Sep-2023 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Modi  | Director | 27-Apr-2021 | Current |
| Akshay Modi | Director | 27-Apr-2021 | Current |
Financial Performance and Corporate Structure Insights of Modi Biotech.
Modi Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 179.18% decrease in profit. The company's net worth Soared by an impressive increase of 106.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Modi Biotech?
In 2023, Modi Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 27 Sep 2022 | ₹6.98 Cr | Open |
State Bank Of India Creation Date: 01 Jun 2022 | ₹130.84 Cr | Open |
How Many Employees Work at Modi Biotech?
Modi Biotech has a workforce of 41 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Modi Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Modi Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
